You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
IGF OT IGF ANGIOCRINE BIOSCIENCE INC
SBC: Angiocrine Bioscience Topic: NCINot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF RADIOPROTECTOR FOR HEAD AND NECK CANCER PERIOD OF PERFORMANCE
SBC: BIOMIMETIX JV LLC Topic: ODNCIThis SBIR Program is to complete the development of a novel metalloporphyrin antioxidant compound BMX to be used as a radioprotector in the treatment of patients with head and neck cancer undergoing radiation therapy This drug product has been produced to GMP quality safety toxicology completed in one species and a high degree of efficacy demonstrated for both protecting against radiation ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS THAT TARGET CANCER STEM CELLS
SBC: NeoStem, Inc. Topic: NCINot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF TREATMENT OF TUBERCULOSIS WITH INHALED DELIVERY OF CLOFAZIMINE
SBC: AEROPHASE, INC. Topic: NIAIDNot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF TITLE SBIR PHASE I VITA CAP TUBE TO PRESERVE CIRCULATING TUMOR CELLS IN BLOOD POP
SBC: VITATEX INC Topic: NCIRecent studies show that proliferative and invasion competent circulating tumor cells CTCs are invaluable in many downstream applications that depend on the ability of the isolated tumor cells to recapitulate tumor growth and metastasis in xenograft mouse models The long term objective of this proposal is to convert the existing Vitatex CTC preparation tube to a closed vacutainer system that is ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF RandD NANOEMULSION FORMULATION AND IND ENABLING STUDIES OF A NOVEL CENTER STEM CELL CYTOTOXIC AGENT
SBC: Targagenix, Inc. Topic: NCINot Available
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF SMOKESCREEN GENETIC SCREENING TOOL FOR TOBACCO DEPENDENCE and TREATMENT APPROACHES POP MOD SUPPLEMENT WITHIN SCOPE AND EXTENSION
SBC: BIOREALM, LLC Topic: NIDANot Available
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF TOPIC CHEMICALLY DEFINED GLYCAN LIBRARIES FOR REFERENCE STANDARDS AND GLYCOMICS RESEARCH JOINT NCI NIGMS PROGRAM
SBC: Glycobia, Inc. Topic: NCINot Available
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
IGF OT IGF CONTRACT TITLE RADIATION MODULATORS FOR HEAD AND NECK CANCERPOP
SBC: SUVICA INC Topic: NCINot Available
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Smartphone Technology for Parents and Teens: Improving Vaccination Uptake
SBC: KLEIN BUENDEL, INC. Topic: NICHDDESCRIPTION provided by applicant Vaccinations for adolescents in the U S tetanus diphtheria and acellular pertussis Tdap meningococcal conjugate vaccine MCV Human Papillomavirus HPV vaccines Gardasil and Cervarex remain well below the Centers for Disease Control and Prevention CDC goals and especially so for the HPV vaccines These vaccine deficits are pronounced among minor ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health